国产阿扎胞苷治疗较高危骨髓增生异常综合征患者的疗效和安全性分析：多中心、前瞻性、单臂研究

OBJECTIVE: To evaluate the efficacy, safety, and pharmacokinetics of the generic azacitidine in Chinese patients with higher-risk myelodysplastic syndromes（MDS）. METHODS: Between October 2013 and 2016, 72 patients were eligible for enrollment at 9 sites from China received generic subcutaneous azaci...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2020
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656073/
https://www.ncbi.nlm.nih.gov/pubmed/33190437
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656073/
https://www.ncbi.nlm.nih.gov/pubmed/33190437
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.10.004

Ejemplares similares